FSLLRY-NH2 TFA

• CAT Number: I045804
• Molecular Formula: C41H61F3N10O10
• Molecular Weight: 910.98
• Purity: ≥95%

FSLLRY-NH2 TFA is a protease-activated receptor 2 (PAR2) inhibitor[1].
Treatment with FSLLRY-NH2 (50 μg per rat administered intranasally at 1 hour postresuscitation) significantly improves neurological outcome and reduces the number of degenerating hippocampal neurons after ACA (asphyxial CA)[1].

Reference

[1]. Umut Ocak, et al. FSLLRY-NH2 Improves Neurological Outcome After Cardiac Arrest in Rats. Turk Neurosurg. 2020;30(2):244-251.
 [Content Brief]